Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01460225 · ClinicalTrials.gov registry record · Phase 4
Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation
A Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT01460225 is a Phase 4 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 19 participants.
The verdict
NCT01460225, a Phase 4 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
This prospective study is designed to evaluate how lubiprostone may affect gastric motor and sensory function.
Interventions
- DRUG lubiprostone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01460225
The ClinicalTrials.gov registry entry for NCT01460225 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lubiprostone is the first listed.
NCT01460225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01460225 about?
NCT01460225 is a clinical study titled "Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation". This prospective study is designed to evaluate how lubiprostone may affect gastric motor and sensory function.
What is the current status of trial NCT01460225?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2007-09. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01460225?
The interventions under investigation include: lubiprostone (DRUG).
Who is sponsoring clinical trial NCT01460225?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.